Anna Mowry has not been actively trading shares of Nautilus Biotechnology during the last ninety days. Most recently, on Friday, August 19th, Anna Mowry bought 17,500 shares of Nautilus Biotechnology stock. The stock was acquired at an average cost of $2.30 per share, with a total value of $40,250.00. Following the completion of the transaction, the chief financial officer now directly owns 56,750 shares of the company's stock, valued at $130,525. Learn More on Anna Mowry's trading history.